RaySearch Laboratories AB (STO:RAY.B), a provider of software for radiation therapy, announced on Friday that it has secured an order worth DKK10.5m (approximately SEK15.4m) from Odense University Hospital, part of the South Denmark Region, for its RayStation treatment planning system.
Odense University Hospital's radiotherapy centre, a leader in automated treatment planning, aims to further expand automation across the entire planning process, from initial assessments to finalised treatment plans. RayStation was selected following an extensive market evaluation focused on supporting continued innovation in automation.
RayStation integrates both machine learning and traditional planning algorithms. Its upcoming version will feature a new auto-optimisation algorithm, currently under development in collaboration with Memorial Sloan Kettering Cancer Center.
Most of the revenue from the order is expected to be recognized in the first quarter of 2025. The agreement excludes a service contract and remains subject to regulatory clearance in certain markets.
(USD1.00 = DKK6.57)
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Frontage expands early phase clinical research capabilities across US and China
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
InSysBio agrees new collaborative project with BeOne Medicines
Physiomics secures new modelling contract with Numab Therapeutics
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Avacta secures FDA clearance for second pre|CISION oncology programme
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis